Similar Items: In vivo neutralization of bee venom lethality by IgY antibodies
- IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
- Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
- IgY technology: producing antibodies from a 3Rs perspective
- IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
- Neutralisation of virulence activity of enterohemorrhagic Escherichia coli O157:H7 in vitro through hyperimmune bovine colostrum
- In vitro inhibitory activity of IgY antibodies against Salmonella ser. newport isolated from horses
Author: Leiva, Carlos Leónidas
- In vitro inhibitory activity of IgY antibodies against Salmonella ser. newport isolated from horses
- IgY technology: producing antibodies from a 3Rs perspective
- Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
- A simple and economic three-step process for producing highly purified Fab’ fragments directly from the egg yolk water-soluble fraction
- IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
- In vivo neutralization of bee venom lethality by IgY antibodies
Author: Geoghegan, Patricia
- Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
- IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
- Clostridium perfringens epsilon toxin induces permanent neuronal degeneration and behavioral changes
- Effects of Clostridium perfringens iota toxin in the small intestine of mice
- In vivo neutralization of bee venom lethality by IgY antibodies